Beam Therapeutics Inc. (BEAM) Free cash flow 2019–2025
Beam Therapeutics Inc. (BEAM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$360.0MFY2025 · since FY2019: -$84.5M → -$360.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$360.0M | -1.1% |
| FY2024 | -$356.2M | -94.7% |
| FY2023 | -$182.9M | -592.3% |
| FY2022 | -$26.4M | +76.6% |
| FY2021 | -$113.1M | -0.9% |
| FY2020 | -$112.1M | -32.6% |
| FY2019 | -$84.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice